
Raymond Chung
Physician · Brigham and Women's Hospital
Credentials: · · · · ·
History
- 2026–Present
- 1994–1995
Transplant Hepatology
- 1993–1994
1982–1986- 1978–1982
Harvard College
Research
A role for hepatitis C virus infection in type II cryoglobulinemia
New England Journal of Medicine · 1992 · 1,212 citations
Analysis of successful immune responses in persons infected with hepatitis C virus
The Journal of Experimental Medicine · 2000 · 1,026 citations
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Case report · New England Journal of Medicine · 2019 · 1,001 citations
- KC
77 papers · 12 as a fellow

55 papers · 5 as a resident
- TS
38 papers · 22 as a fellow
- MG
35 papers
- ES
30 papers · 9 as a fellow
- NU
27 papers · 13 as a resident

27 papers

26 papers
Grants
- 1976–2031
Research Training in Digestive Diseases
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $10.3M · Massachusetts General Hospital
- 1997–2031
Center for Studies of Inflammatory Bowel Disease (CSIBD)
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $347.6K · Massachusetts General Hospital
- 2009–2029
Durable Alteration of the Human Immune System After Infection or Immunotherapy
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $45.8M · Massachusetts General Hospital
- 2023–2028
YAP Signaling in the Pathogenesis of NAFLD in People Living with HIV
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $4M · Massachusetts General Hospital
Clinical trials
- 2023–2031
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Principal investigator · Recruiting · Phase 2
Raymond Chung
- 2020–2021
Pegylated Interferon Lambda Treatment for COVID-19
Principal investigator · Terminated · Phase 2
Raymond Chung
- 2019–2020
HCV Post-Exposure Prophylaxis for Health Care Workers
Principal investigator · Withdrawn · Phase 4
Massachusetts General Hospital
- 2019–2021
Multi-center Study to Transplant Hepatitis-C Infected Kidneys
Principal investigator · Completed · Phase 4
Raymond Chung


